The abstract is read at the publisher; the summary is JClub's.
Vascularized tumor assembloids built by organoid bioprinting form dense, hierarchical, functional microvasculature and hepatic tumor-like structures after implantation, enabling physiologically relevant tumor modeling.
- Why it matters: Tumor microenvironment complexity and heterogeneity limit current in vitro models, so better systems are needed to capture realistic tissue architecture and therapeutic responses.
- What they did: The authors bioprinted VTASs using a cell aggregate-rich living gel with endothelialized hepatic tumor aggregates plus suspended endothelial cells, then assessed drug response, immune co-culture, and in vivo implantation.
- The result: Compared with cell-based or sparsely vascularized models, dense microvasculature VTASs showed reduced apoptosis and delayed intracellular drug accumulation during cisplatin, sorafenib, combination therapy, and doxorubicin screening, and immune co-culture captured monocyte-endothelial interactions.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.